JP2003526614A5 - - Google Patents

Download PDF

Info

Publication number
JP2003526614A5
JP2003526614A5 JP2000598508A JP2000598508A JP2003526614A5 JP 2003526614 A5 JP2003526614 A5 JP 2003526614A5 JP 2000598508 A JP2000598508 A JP 2000598508A JP 2000598508 A JP2000598508 A JP 2000598508A JP 2003526614 A5 JP2003526614 A5 JP 2003526614A5
Authority
JP
Japan
Prior art keywords
compound
mouse
test group
afp
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000598508A
Other languages
English (en)
Japanese (ja)
Other versions
JP4515642B2 (ja
JP2003526614A (ja
Filing date
Publication date
Priority claimed from SE9900941A external-priority patent/SE9900941D0/xx
Application filed filed Critical
Publication of JP2003526614A publication Critical patent/JP2003526614A/ja
Publication of JP2003526614A5 publication Critical patent/JP2003526614A5/ja
Application granted granted Critical
Publication of JP4515642B2 publication Critical patent/JP4515642B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000598508A 1999-03-16 1999-12-28 多価不飽和脂肪酸誘導体およびその使用 Expired - Fee Related JP4515642B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9900941-7 1999-03-16
SE9900941A SE9900941D0 (sv) 1998-12-23 1999-03-16 Novel retinoic acid derivatives and their use
PCT/IB1999/002064 WO2000047589A1 (en) 1998-12-23 1999-12-28 Polyunsaturated fatty acid derivatives and their use

Publications (3)

Publication Number Publication Date
JP2003526614A JP2003526614A (ja) 2003-09-09
JP2003526614A5 true JP2003526614A5 (https=) 2007-02-22
JP4515642B2 JP4515642B2 (ja) 2010-08-04

Family

ID=20414863

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000598508A Expired - Fee Related JP4515642B2 (ja) 1999-03-16 1999-12-28 多価不飽和脂肪酸誘導体およびその使用

Country Status (6)

Country Link
EP (1) EP1161436B1 (https=)
JP (1) JP4515642B2 (https=)
AT (1) ATE243701T1 (https=)
AU (1) AU765465B2 (https=)
CA (1) CA2358436C (https=)
DE (1) DE69909137T2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017341769B2 (en) * 2016-10-13 2021-11-11 Carnot, Llc N-Acylethanolamide derivatives and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55118494A (en) * 1979-03-07 1980-09-11 Toyama Chem Co Ltd Novel phosphorylcholine compound, its preparation, and antitumor agent comprising it
SE9802162D0 (sv) * 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition
CA2358420C (en) * 1999-03-11 2010-03-16 Ardenia Investments Ltd. New compounds for the treatment of cancer

Similar Documents

Publication Publication Date Title
Schwartz et al. Sprouting from chicken embryo dorsal root ganglia induced by nerve growth factor is specifically inhibited by affinity-purified antiganglioside antibodies.
KR860000274B1 (ko) 갱글리오사이드의 분자내 에스테르 유도체의 제조방법
US4987237A (en) Derivatives of monophosphoryl lipid A
FI64164B (fi) Foerfarande foer framstaellning av 2-(2-acylamino-2-desoxi-(d)-glukosyl-3-0)-alkankarboxylsyrapeptid-derivat
US5389530A (en) Methods for the production of antibodies and induction of immune responses to tumor-associated ganagliosides by immunization with gangloiside lactones
AU606909B2 (en) Sialic acid derivatives having active carbonyl group
US5869606A (en) Amino acids peptides or derivatives thereof coupled to fats
CN102001916B (zh) 作为药物活性剂的茚衍生物
US4603137A (en) Immunosuppressive chromone alkaloid
CN106632272B (zh) 白蛋白结合型5-氟尿嘧啶前体药物的合成及应用
WO2000047589A1 (en) Polyunsaturated fatty acid derivatives and their use
JP2003526614A5 (https=)
Hegde et al. A depsipeptide fungal metabolite inhibitor of cholesteryl ester transfer protein
Tsukamoto et al. Metabolism of Drugs. XXXV. Metabolic Fate of Meprobamate.(3). A New Metabolic Pathway of Carbamate Group: The Formation of Meprobamate N-Glucuronide in Animal Body.
JPH0150714B2 (https=)
US4681856A (en) Muramyldipeptide active ester derivatives
EP0874851B1 (en) Macrocyclic compounds made from carbon suboxide units
US4515715A (en) L-Alanyl-D-isoglutamine adamantylamide
Waldmann et al. The inter-relationship of antigenic structure, thymus-independence and adjuvanticity. IV. A general model for B-cell induction
RU2034845C1 (ru) 5- ИЛИ 6-ЗАМЕЩЕННЫЕ СЛОЖНЫЕ ЭФИРЫ β -КАРБОЛИН-3-КАРБОНОВОЙ КИСЛОТЫ, ОБЛАДАЮЩИЕ ПСИХОТРОПНОЙ АКТИВНОСТЬЮ, И ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ ДЛЯ ЛЕЧЕНИЯ ПСИХОТРОПНЫХ ЗАБОЛЕВАНИЙ
US4201866A (en) O-Hemi-succinate of propranolol
JPH05194596A (ja) Tert−ブチルオキシカルボニル−L−チロシル−ペプチドグリカンモノマー及びその125I−標識誘導体、それらの製造法及び用途
Acher et al. A method for fractionation of cerebrosides into classes with different fatty acid compositions
JP2002179577A (ja) 抗腫瘍物質及び抗腫瘍剤
WO2025140549A1 (en) Immune stimulating anti-hbsag antibody conjugates, pharmaceutical compositions, and therapeutic applications